Don't Smash the Platelets
New Apoptosis-Targeting Drug Gets B Cells, Spares Platelets
By Anette Breindl
Friday, January 11, 2013
Researchers have developed an experimental drug, ABT-199, that interferes with anti-apoptotic proteins. Unlike its precursor navitoclax, though, ABT-199 does not interfere with platelet function.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.